Detailed price information for Sionna Therapeutics Inc (SION-Q) from The Globe and Mail including charting and trades.

An increasing number of women with cystic fibrosis can conceive and deliver healthy babies, an occurrence associated with increased CFTRm use.

To help reduce the misuse and misunderstanding of current science, scientific research needs to be explained in language the ...

The Claudin18.2 targeted therapy market offers significant opportunities in treating advanced cancers such as gastric and pancreatic. With one approved therapy and over 70 in clinical trials, ...

Using cryo-EM structure determination, molecular dynamics simulations, and electrophysiological analyses, researchers from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences ...

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best strong buy stocks to invest in under $5. AbCellera Biologics Inc.

As of Friday, February 06, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 6.36%, which has investors questioning ...

In a study published in Nature on January 28, a research team led by Eric H. Xu (Xu Huaqiang) from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, along with Ma Xiong from ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases (CVDs), a leading global cause of mortality, are characterized by complex ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing ...

Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...